CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

8 hedge funds and large institutions have $16.8M invested in Celyad Oncology SA American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
1
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FIG
1
Fortress Investment Group
New York
$15.8M
Osaic Holdings
2
Osaic Holdings
Arizona
$777K
HF
3
HRT Financial
New York
$88K -$3.12K -1,305 -3%
Morgan Stanley
4
Morgan Stanley
New York
$49K -$9.7K -3,958 -17%
Wells Fargo
5
Wells Fargo
California
$42K -$2.42K -1,015 -5%
Citadel Advisors
6
Citadel Advisors
Florida
$35K +$35K +14,598 New
UBS Group
7
UBS Group
Switzerland
$10K +$1.17K +474 +13%
National Bank of Canada
8
National Bank of Canada
Quebec, Canada
$8K
TSS
9
Two Sigma Securities
New York
-$65K -17,786 Closed
Jane Street
10
Jane Street
New York
-$44K -11,122 Closed
TRCT
11
Tower Research Capital (TRC)
New York
-$4K -1,225 Closed